Through a newly published Notice of Special Interest (NOSI), the National Cancer Institute is seeking to stimulate the development of innovative technologies and informatics tools for cancer metabolomics research by leveraging its own programs such as the Informatics Technology for Cancer Research (ITCR) program and the Innovative Molecular Analysis Technologies (IMAT) program.

Refer to the details on specific areas of research interest, submission requirements, and which funding opportunities affiliated with the NOSI are still available.

Metabolites and lipids play key roles in keeping cells healthy and functioning, so improving metabolomics technologies and their accessibility to researchers is advantageous for the advancement of cancer research.